Suchergebnisse - "Pigneur, Frédéric"

PubPharm (5)

1

Quantitative correlation between uptake of Gd-BOPTA on hepatobiliary phase and tumor molecular features in patients with benign hepatocellular lesions

enthalten in: European radiology | 2018

von Reizine, E. | Amaddeo, G. | Pigneur, F. | +9

2

Differentiating focal nodular hyperplasia from hepatocellular adenoma : Is hepatobiliary phase MRI (HBP-MRI) using linear gadolinium chelates always useful?

enthalten in: Abdominal radiology (New York) | 2018

von Roux, M. | Pigneur, F. | Baranes, L. | +12

ErratumIn: Abdom Radiol (NY). 2017 Dec 11;:. - PMID 29230554

3

Response to "Quantitative analysis of hepatocellular adenoma and focal nodular hyperplasia in the hepatobiliary phase : External validation of llcer method using gadobenate dimeglumine as contrast agent"

enthalten in: Journal of magnetic resonance imaging : JMRI | 2018

von Roux, M. | Pigneur, F. | Luciani, A.

CommentOn: J Magn Reson Imaging. 2015 Nov;42(5):1249-58. - PMID 25851028

4

Impact of hepatobiliary phase liver MRI versus Contrast-Enhanced Ultrasound after an inconclusive extracellular gadolinium-based contrast-enhanced MRI for the diagnosis of benign hepatocellular tumors

enthalten in: Abdominal radiology (New York) | 2017

von Tselikas, L. | Pigneur, F. | Roux, M. | +11

5

Differentiation of focal nodular hyperplasia from hepatocellular adenoma : Role of the quantitative analysis of gadobenate dimeglumine-enhanced hepatobiliary phase MRI

enthalten in: Journal of magnetic resonance imaging : JMRI | 2015

von Roux, M. | Pigneur, F. | Calderaro, J. | +11

CommentIn: J Magn Reson Imaging. 2018 Mar;47(3):862-863. - PMID 28580722

1
[1]